If you are interested in participating in the following trial, please contact the relevant Trial Chairperson or Trial Centre Data Manager.

TROG 03.04 - Randomised trial investigating the effect on survival and PSA control of different durations of adjuvant androgen deprivation in association with definitive radiation treatment for localised carcinoma of the prostate (RADAR).

Date first patient entered: 20 October 2003

Target Accrual: 1000

Aim: The principal objective of the trial is to test the hypothesis that 12 months adjuvant androgen deprivation using Leuprorelin acetate starting immediately after standard therapy (ie 6 months of Leuprorelin acetate before and during radiotherapy) will improve biochemical (PSA) relapse free survival (PSA-RFS) when compared with standard therapy alone.
[ Download - Trial Synopsis (PDF - 302 KB) ]

Technical Information

Trial Contacts:
Trial Chairpersons
Dr David Lamb
Wellington Hospital, NZ
Fax: +64 4 385 5843

Professor Jim Denham
Newcastle Mater Hospital, Newcastle, NSW
Fax: +61 2 4921 1465

Trial Centre Project Manager
Jean Ball
Radiation Oncology RADAR
Newcastle Mater Misericordiae Hospital
Fax: +61 2 4921 1153

More Information

[ Open Trials - Home ]